Sort
130,381 grants matching “hiv”
Clinical Development of Chimp Adenovirus Vectors
$2,276,038Hildegund C. J. Ertl · Wistar Institute · U19 · FY2009 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,275,272Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Consumer Products and Therapeutics Research Program
$2,275,023Kyla Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
COMPREHENSIVE AND INTEGRATED HIV PREVENTION INTERVENTIONS FOR A HIV-FREE NYANZA:
$2,275,000Kawango Agot · Impact Research And Development Org · U2G · FY2011 · PS
PS04-012, HIV PREVENTION PROJECTS
$2,274,936Andrew Gans · New Mexico State Department Of Health · U62 · FY2008 · PS
Women's Interagency HIV Study (WIHS) III
$2,274,131Suny Downstate Medical Center · U01 · FY2003 · AI
HIV Center for Clinical and Behavioral Studies
$2,273,717New York State Psychiatric Institute · P30 · FY2005 · MH
The Military HIV Research Program (MHRP) Clinical Trial Unit
$2,272,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2021 · AI
Safety Evaluation of Anti-Infective Agents
$2,272,188Jon Carl Mirsalis · Sri International · N01 · FY2011 · AI
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,271,824Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2022 · HL
PS04-012, HIV PREVENTION PROJECTS
$2,270,963Donald J Torres · New Mexico State Department Of Health · U62 · FY2007 · PS
CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS
$2,270,875Kim Johnson · National Minority Aids Council · U65 · FY2007 · PS
Integrating preclinical models to develop converging mechanistic data in co-occurring HIV and substance use
$2,270,625Jacqueline M Barker · Drexel University · DP2 · FY2020 · DA
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge Translation
$2,270,589Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2025 · DA
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa
$2,270,572W. Henry Henry Boom · Case Western Reserve University · R01 · FY2019 · AI
HIV Subtype C Alphavirus Vaccine Design &Development
$2,270,241Alphavax Human Vaccines, Inc. · U01 · FY2002 · AI
INCREASING ACCESS TO HIV CONFIDENTIAL COUNSELING AND TESTING (VCT) AND ENHA
$2,270,000Neeraj Kak · University Research Co, Llc · U62 · FY2008 · PS
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) - III
$2,269,828Bridget F Grant · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Molecular Analysis Of Retroviral Genes And Their Products
$2,269,761Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Bone Marrow Transplantation in Human Disease
$2,269,507Richard J Jones · Johns Hopkins University · P01 · FY2019 · CA
Role of B Lymphocytes In HIV Infection And Pathogenesis
$2,269,182Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
ETIB Clinical Research Core
$2,268,710Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,268,617Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination
$2,268,093Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2013 · AI
National Drug Abuse Treatment Clinical Trials Network
$2,267,457Walter Nmn Ling · University Of California Los Angeles · U10 · FY2009 · DA